Section(X) | Body System(W) | Operation(0) | Approach(3) | Device / Substance / Technology(9) | Qualifier(2) | Body Part(4) |
New Technology | Anatomical Regions | Introduction | Percutaneous | Satralizumab-mwge | New Technology Group 2 | Central Vein |
No record found
Change Type | Change Date | Previous Descriptor |
Code Deleted | 09-30-2022 | Introduction of Defibrotide Sodium Anticoagulant into Central Vein, Percutaneous Approach, New Technology Group 2 |
Code Added | 10-01-2016 |